Russell Skibsted

Proove Biosciences, Inc. provides genetic testing services. It engages in the research, investigation and development of patent-protected precision medicine profiles that combine genetic and clinical data into reports to help clinicians individualize medicine selection and dosing for chronic pain. The company was founded by Brian Meshkin in 2009 and is headquartered in Irvine, CA.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.

Asset Management Co. is a venture capital firm. The company was founded in 1965 and is headquartered in East Palo Alto, CA.